Nomura Holdings Inc. Has $59 Million Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Nomura Holdings Inc. trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 16.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 852,624 shares of the company's stock after selling 171,145 shares during the period. Nomura Holdings Inc. owned approximately 0.68% of Henry Schein worth $59,002,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of HSIC. NorthRock Partners LLC bought a new position in shares of Henry Schein during the 4th quarter valued at $339,000. OMERS ADMINISTRATION Corp grew its stake in Henry Schein by 19.9% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 5,403 shares of the company's stock valued at $374,000 after buying an additional 895 shares during the last quarter. Marathon Partners Equity Management LLC bought a new stake in Henry Schein during the fourth quarter valued at about $6,055,000. Millennium Management LLC grew its position in shares of Henry Schein by 451.7% in the fourth quarter. Millennium Management LLC now owns 497,554 shares of the company's stock valued at $34,431,000 after purchasing an additional 407,376 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its position in shares of Henry Schein by 2.7% during the 4th quarter. Janus Henderson Group PLC now owns 10,709 shares of the company's stock worth $741,000 after purchasing an additional 286 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Trading Down 0.2%

Shares of HSIC stock traded down $0.18 on Monday, reaching $71.88. 389,859 shares of the stock were exchanged, compared to its average volume of 1,640,378. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The stock has a market cap of $8.75 billion, a PE ratio of 29.58, a P/E/G ratio of 2.13 and a beta of 0.87. The stock has a 50 day moving average price of $67.34 and a 200 day moving average price of $71.47.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's quarterly revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.10 EPS. Equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HSIC. Jefferies Financial Group raised their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Piper Sandler reduced their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. StockNews.com cut Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Wells Fargo & Company cut their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Finally, UBS Group decreased their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $79.30.

Insider Activity at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by corporate insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.